|
1
|
Wencel K, Dyaczyńska-Herman A and Wencel
T: Plasma clotting and fibrinolysis parameters in patients with
spontaneous and posttraumatic SAH. Clin Neuro Neurosurg. 99(Suppl
1): 70. 1997. View Article : Google Scholar
|
|
2
|
Arreche ND, Sarati LI, Martinez CR, Fellet
AL and Balaszczuk AM: Contribution of caveolin-1 to ventricular
nitric oxide in age-related adaptation to hypovolemic state. Regul
Pept. 179:43–49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Agyemang C, van Oeffelen AA, Norredam M,
et al: Ethnic disparities in ischemic stroke, intracerebral
hemorrhage, and subarachnoid hemorrhage incidence in The
Netherlands. Stroke. 45:3236–3242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laskowitz DT and Kolls BJ: Neuroprotection
in subarachnoid hemorrhage. Stroke. 41(Suppl 10): S79–S84. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Connolly ES Jr, Rabinstein AA, Carhuapoma
JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech
AM, Ogilvy CS, et al: Guidelines for the management of aneurysmal
subarachnoid hemorrhage: A guideline for healthcare professionals
from the American heart association/American stroke association.
Stroke. 43:1711–1737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pluta RM: Introduction to problems of
postsubarachnoid hemorrhage delayed cerebral vasospasmAnimal Models
of Acute Neurological Injuries II. Humana Press; New York, NY: pp.
459–464. 2012, View Article : Google Scholar
|
|
7
|
Anderson GB, Ashforth R, Steinke DE, et
al: CT angiography for the detection of cerebral vasospasm in
patients with acute subarachnoid hemorrhage. Am J Neuroradiol.
21:1011–1015. 2000.PubMed/NCBI
|
|
8
|
Specogna AV: Subarachnoid hemorrhage
diagnosis. JAMA. 311:2012014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang W and Zhou Z: Research advances on
pathogenesy of cerebral vasospasm after suharachnoid hemorrhage.
Zhong Guo Nao Xue Guan Bing Za Zhi. 7:215–219. 2010.(In
Chinese).
|
|
10
|
Roos YB, Dijkgraaf MG, Albrecht KW, Beenen
LF, Groen RJ, de Haan RJ and Vermeulen M: Direct costs of modern
treatment of aneurysmal subarachnoid hemorrhage in the first year
after diagnosis. Stroke. 33:1595–1599. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pluta RM: Delayed cerebral vasospasm and
nitric oxide: Review, new hypothesis, and proposed treatment.
Pharmacol Ther. 05:23–56. 2005. View Article : Google Scholar
|
|
12
|
Suzuki H, Kanamaru K, Tsunoda H, Inada H,
Kuroki M, Sun H, Waga S and Tanaka T: Heme oxygenase-1 gene
induction as an intrinsic regulation against delayed cerebral
vasospasm in rats. J Clin Invest. 104:59–66. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Varsos VG, Liszczak TM, Han DH, Kistler
JP, Vielma J, Black PM, Heros RC and Zervas NT: Delayed cerebral
vasospasm is not reversible by aminophylline, nifedipine, or
papaverine in a ‘two-hemorrhage’ canine model. J Neurosurg.
58:11–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Manabe K, Ito H, Matsuda H, et al:
Hyperpolarization induced by vasoactive substances in intact
guinea-pig endocardial endothelial cells. J Physiol. 484:25–40.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rabinstein AA, Lanzino G and Wijdicks EF:
Multidisciplinary management and emerging therapeutic strategies in
aneurysmal subarachnoid haemorrhage. Lancet Neurol. 9:504–519.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rothberg KG, Heuser JE, Donzell WC, Ying
YS, Glenney JR and Anderson RG: Caveolin, a protein component of
caveolae membrane coats. Cell. 68:673–82. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang H and Zou W: Caveolin-1 and Breast
Cancer. Chinese Zhong Guo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue
Bao. 23:20–26. 2007.(In Chinese).
|
|
18
|
Sampson MJ, Lovell RS and Craigen WJ: The
murine voltage-dependent anion channel gene family. Conserved
structure and function. J Biol Chem. 272:18966–18973. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hurlstone AF, Reid G, Reeves JR, Fraser J,
Strathdee G, Rahilly M, Parkinson EK and Black DM: Analysis of the
CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and
tumour-derived cell lines. Oncogene. 18:1881–1890. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prinetti A, Prioni S, Loberto N, Aureli M,
Chigorno V and Sonnino S: Regulation of tumor phenotypes by
caveolin-1 and sphingolipid-controlled membrane signaling
complexes. Biochim Biophys Acta. 1780:585–596. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Botos E, Klumperman J, Oorschot V, Igyártó
B, Magyar A, Oláh M and Kiss AL: Caveolin-1 is transported to
multi-vesicular bodies after albumin-induced endocytosis of
caveolae in HepG2 cells. J Cell Mol Med. 12:1632–1639. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arakawa R, Abedohmae S, Asai M, Ito JI and
Yokoyama S: Involvement of caveolin-1 in cholesterol enrichment of
high density lipoprotein during its assembly by apolipoprotein and
THP-1 cells. J Lipid Res. 41:1952–1962. 2001.
|
|
23
|
Yu Q, Chen X, Fang X, Chen Q and Hu C:
Caveolin-1 aggravates cigarette smoke extract-induced MUC5AC
secretion in human airway epithelial cells. Int J Mol Med.
35:1435–1442. 2015.PubMed/NCBI
|
|
24
|
Smart EJ, Graf GA, McNiven MA, Sessa WC,
Engelman JA, Scherer PE, Okamoto T and Lisanti MP: Caveolins,
liquid-ordered domains, and signal transduction. Mol Cell Biol.
19:7289–7304. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song L, Liu J, Zou W and An LJ: Role of
Caveolin-1 in cell senescence and senescent dieases. Zhong Guo
Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao. 08:712–720. 2011.(In
Chinese).
|
|
26
|
Jasmin JF, Malhotra S, Singh Dhallu M,
Mercier I, Rosenbaum DM and Lisanti MP: Caveolin-1 deficiency
increases cerebral ischemic injury. Circ Res. 100:721–729. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen J, Ma S, Chan P, Lee W, Fung PC,
Cheung RT, Tong Y and Liu KJ: Nitric and oxide down-regulates
caveolin-1 expression in rat brains during focal cerebral ischemia
and reperfusion injury. J Neurochem. 96:1078–1089. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee JY, Huang DL, Keep R and Sagher O:
Characterization of an improved double hemorrhage rat model for the
study of delayed cerebral vasospasm. J Neurosci Methods.
168:358–366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bederson JB, Pitts LH, Tsuji M, Nishimura
MC, Davis RL and Bartkowski H: Rat middle cerebral artery
occlusion: Evaluation of the model and development of a neurologic
examination. Stroke. 17:472–476. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vellimana AK, Milner E, Azad TD, Harries
MD, Zhou ML, Gidday JM, Han BH and Zipfel GJ: Endothelial nitric
oxide synthase mediates endogenous protection against subarachnoid
hemorrhage-induced cerebral vasospasm. Stroke. 42:776–782. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kassell NF, Sasaki T, Colohan AR and Nazar
G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Stroke. 1985.16:562–572. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jia L and Sun BL: Establishment of an
animal model of cerebral vasospasm following subarachnoid
hemorrhage. J Clinical Rehabilitative Tissue Engineering Research.
13:8147–8150. 2009.
|
|
33
|
Sugawara T, Ayer R, Jadhav V and Zhang JH:
A new grading system evaluating bleeding scale in filament
perforation subarachnoid hemorrhage rat model. J Neurosci Methods.
167:327–334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marbacher S, Fandino J and Kitchen ND:
Standard intracranial in vivo animal models of delayed cerebral
vasospasm. Br J Neurosurg. 24:415–434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Güresir E, Raabe A, Jaiimsin A, Dias S,
Raab P, Seifert V and Vatter H: Histological evidence of delayed
ischemic brain tissue damage in the rat double-hemorrhage model. J
Neurol Sci. 293:18–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yanamoto H, Kataoka H, Nakajo Y and Iihara
K: The role of the host defense system in the development of
cerebral vasospasm: Analogies between atherosclerosis and
subarachnoid hemorrhage. Eur Neurol. 68:329–343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chaichana KL, Pradilla G, Huang J and
Tamargo RJ: Role of inflammation (leukocyte-endothelial cell
interactions) in vasospasm after subarachnoid hemorrhage. World
Neurosurg. 73:22–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Anuntasethakul T, Srikiatkhachorn A,
Maneesri S, Patumraj S and Kasantikul V: Ultrastructural changes in
endothelial cells of cerebral microvessels after exposure to nitric
oxide donor. Neuropathol. 19:259–266. 1999. View Article : Google Scholar
|
|
39
|
Pluta RM, Andre D, George G, Gladwin MT
and Oldfield EH: Nitrite infusions to prevent delayed cerebral
vasospasm in a primate model of subarachnoid hemorrhage. JAMA.
293:1477–1484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kevil CG and Patel RP: Preserving vessel
function during ischemic disease: New possibilities of inorganic
nitrite therapy. Expert Rev Cardiovasc Ther. 6:1175–1179. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Duncan C, Dougall H, Johnston P, Green S,
Brogan R, Leifert C, Smith L, Golden M and Benjamin N: Chemical
generation of nitric oxide in the mouth from the enterosalivary
circulation of dietary nitrate. Nat Med. 1:546–551. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dora KA, Doyle MP and Duling BR: Elevation
of intracellular calcium in smooth muscle causes endothelial cell
generation of NO in arterioles. PNAS. 94:6529–6534. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Corpas FJ, Barroso JB, Carreras A, Quirós
M, León AM, Romero-Puertas MC, Esteban FJ, Valderrama R, Palma JM,
Sandalio LM, et al: Cellular and subcellular localization of
endogenous nitric oxide in young and senescent pea plants. Plant
Physiol. 136:2722–2733. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Russell FD and Molenaar P: The human heart
endothelin system: ET-1 synthesis, storage, release and effect.
Trends Pharmacol Sci. 21:353–359. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Thyberg J: Caveolin-1 and caveolae act as
regulators of mitogenic signaling in vascular smooth muscle cells.
Arterioscler Thrombo Vasc Biol. 23:1481–1483. 2003. View Article : Google Scholar
|
|
46
|
Penumathsa SV, Koneru S, Samuel SM, Maulik
G, Bagchi D, Yet SF, Menon VP and Maulik N: Strategic targets to
induce neovascularization by resveratrol in hypercholesterolemic
rat myocardium: role of caveolin-1, eNOS, HO-1 and VEGF. Free Radic
Biol Med. 45:1027–1034. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang X, Zhou Z, Liu J, Feng B, Zhang J
and Huang W: Relationship between caveolin-1 and proliferation of
basilar artery smooth muscle in rabbit model of subarachnoid
hemorrhage. Journal of Third Military Medical University.
33:830–834. 2011.
|
